Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
50.10    -0.80 (-1.57%)
Bid:
50.20
Ask:
50.80
Spread: 0.60 (1.195%)
Market Cap: £317.06m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

FORM 8 (OPD)

11 Feb 2021 07:00

RNS Number : 6864O
Marston's PLC
11 February 2021
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

MARSTON'S PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

MARSTON'S PLC

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

8 February 2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

 

TOTAL:

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Interests held by the directors of Marston's Plc and their close relatives and related trusts:

 

Name

Number of ordinary shares

Percentage of total issued share capital (excluding share options) (%)

Andrew Andrea

332,773

0.050%

Ralph Findlay

1,290,475

0.195%

Carolyn Bradley

25,000

0.004%

Bridget Lea

50,000

0.008%

Octavia Morley

29,634

0.004%

Matthew Roberts

25,000

0.004%

William Rucker

200,000

0.030%

 

(b) Interests held as options or awards under the share plans of Marston's PLC by the directors of Marston's PLC and their close relatives and related trusts who are not exempt principal traders for the purposes of Rule 8 of the Code:

Name

Share Plan

Number of ordinary shares (under option)

Vesting date

Exercise price (per share) (£)

Andrew Andrea

2018 LTIP

473,033

2021

Nil

2019 LTIP

372,124

2022

Nil

Ralph Findlay

2018 SAYE

20,224

2021

0.89

2018 LTIP

706,287

2021

Nil

2019 LTIP

555,620

2022

Nil

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

10 February 2021

Contact name:

Anne-Marie Brennan, Group Secretary

Telephone number:

+44 (0) 1902 329516

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEDBLFFFLLEBBL
Date   Source Headline
3rd Mar 20229:45 amRNSHolding(s) in Company
18th Feb 20221:09 pmRNSHolding(s) in Company
25th Jan 20222:35 pmRNSTrading for the period to 22 Jan 2022 - Correction
25th Jan 20222:20 pmRNSResult of AGM
25th Jan 20227:00 amRNSTrading for the 16-week period to 22 January 2022
10th Jan 20223:55 pmRNSBlock listing Interim Review
20th Dec 20214:15 pmRNSAnnual Financial Report
7th Dec 202111:11 amRNSDirector/PDMR Shareholding
30th Nov 20217:00 amRNSRESULTS FOR THE 52 WEEKS ENDED 2 OCTOBER 2021
19th Oct 20219:05 amRNSHolding(s) in Company
13th Oct 20217:00 amRNSYear end trading update
30th Sep 202110:43 amRNSDisclosure of 2020/21 LTIP performance targets
16th Sep 20213:00 pmRNSDirector Declaration re: New Directorship
9th Sep 20212:30 pmRNSDirector/PDMR Shareholding
28th Jul 20217:00 amRNSTrading Update
20th Jul 20217:08 amRNSDirectorate Change
13th Jul 20218:36 amRNSBlock listing Interim Review
6th Jul 20217:00 amRNSAppointment of Chief Financial Officer
1st Jun 20212:26 pmRNSTotal Voting Rights
25th May 20212:00 pmRNSDirector/PDMR Shareholding
19th May 20217:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 3 APRIL 2021
12th May 20217:00 amRNSAppointment of Chief Executive Officer
4th May 20213:04 pmRNSTotal Voting Rights
7th Apr 20217:00 amRNSFinancial Waiver and Reopening Update
26th Mar 202110:34 amRNSCOVID Update: Result of Noteholder Consent Request
11th Mar 20217:00 amRNSRalph Findlay to step down, September 2021
5th Mar 20217:00 amRNSAnalyst update transaction to operate SABrain pubs
4th Mar 20218:07 amRNSCOVID-19 Update re: Noteholder Consent Request
12th Feb 20213:20 pmRNSForm 8.3 - Marston's plc
12th Feb 20211:31 pmBUSForm 8.3 - MARSTON'S PLC
12th Feb 202111:24 amRNSForm 8.5 (EPT/RI)- Marston’s plc
11th Feb 20211:21 pmBUSForm 8.3 - MARSTON'S PLC
11th Feb 20211:19 pmRNSForm 8.3 - Marston's PLC
11th Feb 202112:00 pmRNSForm 8.5 (EPT/RI) Martson's Plc
11th Feb 202111:48 amRNSForm 8.3 - Marston's PLC
11th Feb 202111:40 amRNSForm 8.5 (EPT/RI) - Marston’s plc
11th Feb 202111:01 amRNSForm 8.5 (EPT/RI) - Marston’s plc
11th Feb 20217:46 amRNSUpdate on possible offer: No intention to bid
11th Feb 20217:00 amRNSStatement regarding Marston's PLC
11th Feb 20217:00 amRNSFORM 8 (OPD)
10th Feb 20213:20 pmRNSForm 8.3 - Marston's PLC
10th Feb 20213:03 pmRNSDirector/PDMR Shareholding
10th Feb 20212:23 pmRNSForm 8.3 -Marston's plc
10th Feb 202112:39 pmRNSForm 8.3 - Marston's PLC
10th Feb 202112:04 pmRNSForm 8.3 - Marston's PLC
10th Feb 202112:00 pmRNSForm 8.5 (EPT/RI) Martson's Plc
10th Feb 202111:38 amBUSForm 8.3 - MARSTON'S PLC
10th Feb 202111:13 amRNSForm 8.5 (EPT/RI) - Marston’s plc
10th Feb 202110:33 amRNSForm 8.5 (EPT/RI) - Marston’s plc
10th Feb 20218:44 amBUSForm 8.3 - MARSTONS PLC AMENDMENT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.